title: Heparin-induced thrombocytopenia: successful biological and clinical management with lepirudin despite severe renal impairment.
authors.forename: Céline
authors.initials: C
authors.lastname: Desconclois
authors.forename: Catherine
authors.initials: C
authors.lastname: Ract
authors.forename: Tewfik
authors.initials: T
authors.lastname: Boutekedjiret
authors.forename: Martine
authors.initials: M
authors.lastname: Alhenc-Gelas
authors.forename: Jacques
authors.initials: J
authors.lastname: Duranteau
authors.forename: Marie
authors.initials: M
authors.lastname: Dreyfus
authors.forename: Valerie
authors.initials: V
authors.lastname: Proulle
mesh_terms: D000369:Aged, 80 and over; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use*; D006629:Hirudins; D006801:Humans; D007674:Kidney Diseases / Q000150:complications*; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000150:complications / Q000628:therapy; D013997:Time Factors; D016896:Treatment Outcome; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D005343:Fibrinolytic Agents; D006629:Hirudins; D011994:Recombinant Proteins; D014859:Warfarin; D006493:Heparin; C083544:lepirudin